2044 | Humans |
1534 | Female |
1362 | Male |
1205 | Adult |
722 | Adolescent |
681 | Middle Aged |
646 | Young Adult |
613 | HIV Infections (epidemiology) |
607 | Socioeconomic Factors |
573 | HIV Infections (drug therapy) |
497 | HIV Infections (prevention & control) |
431 | South Africa |
383 | South Africa (epidemiology) |
350 | HIV Infections (psychology) |
322 | Risk Factors |
304 | Prevalence |
297 | Anti-HIV Agents (therapeutic use) |
294 | Cross-Sectional Studies |
285 | Child |
271 | Health Knowledge, Attitudes, Practice |
270 | HIV Infections (transmission) |
263 | Surveys and Questionnaires |
232 | HIV Infections (complications) |
217 | Pregnancy |
203 | HIV Infections (diagnosis) |
203 | CD4 Lymphocyte Count |
169 | HIV Infections (virology) |
163 | Africa South of the Sahara (epidemiology) |
160 | Aged |
158 | Infant |
146 | Child, Preschool |
142 | Anti-Retroviral Agents (therapeutic use) |
141 | Qualitative Research |
134 | HIV Infections (immunology) |
133 | Sexual Behavior |
130 | Risk-Taking |
130 | Africa South of the Sahara |
129 | Viral Load |
127 | Acquired Immunodeficiency Syndrome (epidemiology) |
125 | Interviews as Topic |
124 | Developing Countries |
119 | Social Support |
118 | Treatment Outcome |
116 | Rural Population |
115 | Antiretroviral Therapy, Highly Active |
114 | HIV Infections (mortality) |
113 | Sexual Partners |
113 | Infectious Disease Transmission, Vertical (prevention & control) |
113 | Cohort Studies |
111 | Social Stigma |
107 | Incidence |
104 | Sex Factors |
103 | Prospective Studies |
96 | Health Services Accessibility |
96 | Age Factors |
95 | Retrospective Studies |
95 | Infant, Newborn |
89 | HIV Infections (therapy) |
89 | HIV Infections (economics) |
86 | HIV-1 |
84 | Acquired Immunodeficiency Syndrome (prevention & control) |
83 | Focus Groups |
83 | Condoms (utilization) |
80 | Logistic Models |
78 | Zambia |
78 | Anti-HIV Agents (administration & dosage) |
77 | AIDS-Related Opportunistic Infections (epidemiology) |
72 | HIV Infections (ethnology) |
70 | Counseling |
70 | Acquired Immunodeficiency Syndrome (psychology) |
68 | Time Factors |
67 | Tuberculosis (epidemiology) |
67 | Sexual Behavior (psychology) |
67 | Health Surveys |
66 | HIV-1 (genetics) |
65 | Acquired Immunodeficiency Syndrome (drug therapy) |
63 | Zambia (epidemiology) |
62 | Urban Population |
60 | Poverty |
59 | Sexual Behavior (statistics & numerical data) |
59 | Patient Acceptance of Health Care (statistics & numerical data) |
59 | Follow-Up Studies |
58 | HIV-1 (immunology) |
57 | Family Characteristics |
56 | HIV Infections |
56 | Africa |
55 | Program Evaluation |
55 | Patient Acceptance of Health Care |
55 | Medication Adherence |
55 | Educational Status |
54 | HIV-1 (isolation & purification) |
53 | Health Policy |
53 | HIV-1 (drug effects) |
52 | AIDS-Related Opportunistic Infections (drug therapy) |
51 | Antiretroviral Therapy, Highly Active (methods) |
50 | Prejudice |
50 | Patient Acceptance of Health Care (psychology) |
50 | Global Health |
50 | Acquired Immunodeficiency Syndrome |
49 | Uganda (epidemiology) |
48 | Stereotyping |
47 | Medication Adherence (statistics & numerical data) |
46 | Multivariate Analysis |
45 | Longitudinal Studies |
45 | HIV Seropositivity (epidemiology) |
45 | Caregivers (psychology) |
45 | Attitude to Health |
44 | Tuberculosis (drug therapy) |
44 | Culture |
43 | Medication Adherence (psychology) |
43 | Interpersonal Relations |
43 | Demography |
43 | Aged, 80 and over |
41 | Sexual Partners (psychology) |
41 | Population Surveillance |
41 | Acquired Immunodeficiency Syndrome (transmission) |
40 | Risk Assessment |
40 | HIV |
40 | Antitubercular Agents (therapeutic use) |
40 | Anti-HIV Agents (adverse effects) |
40 | Adaptation, Psychological |
40 | Acquired Immunodeficiency Syndrome (economics) |
39 | Age Distribution |
39 | Acquired Immunodeficiency Syndrome (complications) |
38 | Pregnancy Complications, Infectious (drug therapy) |
38 | HIV Seropositivity (psychology) |
38 | Disease Progression |
37 | Ghana |
37 | Genotype |
36 | Uganda |
36 | Rural Population (statistics & numerical data) |
36 | Pilot Projects |
36 | Motivation |
36 | HIV Infections (blood) |
36 | Case-Control Studies |
36 | Acquired Immunodeficiency Syndrome (mortality) |
35 | Sex Distribution |
35 | AIDS Serodiagnosis |
34 | Truth Disclosure |
34 | Residence Characteristics |
34 | Randomized Controlled Trials as Topic |
34 | Quality of Life |
34 | Health Services Needs and Demand |
34 | Disease Outbreaks |
34 | AIDS-Related Opportunistic Infections (diagnosis) |
33 | Pregnancy Complications, Infectious (epidemiology) |
33 | Communication |
33 | Animals |
32 | Social Class |
32 | Regression Analysis |
32 | Pregnancy Complications, Infectious (prevention & control) |
32 | Politics |
32 | International Cooperation |
32 | Health Status |
32 | HIV Infections (pathology) |
31 | Virus Diseases |
31 | Kenya |
31 | Disease |
31 | Comorbidity |
30 | Risk Reduction Behavior |
30 | Patient Compliance |
30 | Odds Ratio |
30 | Drug Therapy, Combination |
29 | Zimbabwe (epidemiology) |
29 | Social Environment |
29 | Models, Theoretical |
29 | Mass Screening |
29 | Kenya (epidemiology) |
29 | Health Education |
29 | HIV Seropositivity (drug therapy) |
29 | Economics |
29 | African Continental Ancestry Group |
28 | Tanzania (epidemiology) |
27 | Tuberculosis (complications) |
27 | Cost-Benefit Analysis |
27 | Attitude of Health Personnel |
27 | Africa (epidemiology) |
26 | Survival Analysis |
26 | Sexually Transmitted Diseases (prevention & control) |
26 | Malawi |
26 | Ghana (epidemiology) |
26 | Drug Resistance, Viral |
26 | AIDS-Related Opportunistic Infections (microbiology) |
26 | AIDS-Related Opportunistic Infections (immunology) |
25 | Sexually Transmitted Diseases (epidemiology) |
25 | Perception |
25 | Homosexuality, Male |
25 | Anti-HIV Agents (economics) |
25 | AIDS-Related Opportunistic Infections (mortality) |
24 | Vulnerable Populations |
24 | Unsafe Sex (statistics & numerical data) |
24 | Mass Screening (methods) |
24 | Alcohol Drinking (epidemiology) |
24 | Acquired Immunodeficiency Syndrome (ethnology) |
23 | Phylogeny |
23 | Mothers (psychology) |
23 | Health Services Accessibility (statistics & numerical data) |
23 | Health Behavior |
23 | HIV-1 (classification) |
23 | Cultural Characteristics |
22 | World Health Organization |
22 | Reproducibility of Results |
22 | HIV Infections (physiopathology) |
22 | Epidemiologic Methods |
22 | Drug Administration Schedule |
22 | Decision Making |
22 | AIDS-Related Opportunistic Infections (prevention & control) |
21 | Zimbabwe |
21 | Women's Health |
21 | Tanzania |
21 | Poverty (statistics & numerical data) |
21 | Nigeria (epidemiology) |
21 | Mothers |
21 | Infectious Disease Transmission, Vertical |
21 | Health Promotion |
21 | HIV Infections (genetics) |
21 | Feasibility Studies |
21 | Cost of Illness |
21 | Condoms |
21 | Acquired Immunodeficiency Syndrome (therapy) |
21 | AIDS Vaccines (immunology) |
20 | Tuberculosis, Pulmonary (epidemiology) |
20 | Tuberculosis (prevention & control) |
20 | Tuberculosis (immunology) |
20 | Sexual Behavior (ethnology) |
20 | Quality of Life (psychology) |
20 | Pregnancy Complications, Infectious (diagnosis) |
20 | Population |
20 | Nigeria |
20 | Malawi (epidemiology) |
20 | HIV Seropositivity (diagnosis) |
20 | Family |
20 | Counseling (utilization) |
20 | Antiretroviral Therapy, Highly Active (adverse effects) |
20 | Adolescent Behavior |
20 | AIDS-Related Opportunistic Infections (complications) |
19 | Severity of Illness Index |
19 | Sensitivity and Specificity |
19 | Senegal |
19 | Population Dynamics |
19 | Patient Compliance (statistics & numerical data) |
19 | Nevirapine (therapeutic use) |
19 | HIV-1 (physiology) |
19 | HIV Seropositivity |
19 | Cluster Analysis |
19 | Child, Orphaned (statistics & numerical data) |
19 | Cause of Death |
19 | Anti-Retroviral Agents (administration & dosage) |
19 | Acquired Immunodeficiency Syndrome (immunology) |
18 | Unsafe Sex (psychology) |
18 | United States |
18 | Tuberculosis, Pulmonary (drug therapy) |
18 | Tuberculosis (diagnosis) |
18 | Treatment Failure |
18 | Tenofovir |
18 | Sequence Analysis, DNA |
18 | RNA, Viral (blood) |
18 | Proportional Hazards Models |
18 | Health Status Disparities |
18 | Health Services Research |
18 | Health Promotion (methods) |
18 | Health Education (methods) |
18 | Health Care Surveys |
18 | HIV Seroprevalence |
18 | Delivery of Health Care |
18 | Coinfection |
18 | Child, Orphaned |
18 | Ambulatory Care Facilities |
18 | Africa South of the Sahara (ethnology) |
18 | Adenine (analogs & derivatives) |
17 | Urban Population (statistics & numerical data) |
17 | Self Report |
17 | Research Design |
17 | Primary Health Care |
17 | Patient Education as Topic |
17 | Molecular Sequence Data |
17 | Home Care Services |
17 | History, 20th Century |
17 | Delivery of Health Care (economics) |
17 | Breast Feeding |
17 | Anti-HIV Agents (pharmacology) |
17 | AIDS Serodiagnosis (utilization) |
16 | Tuberculosis (mortality) |
16 | Stress, Psychological (psychology) |
16 | Self Efficacy |
16 | Self Disclosure |
16 | Schools |
16 | Safe Sex |
16 | Rural Health |
16 | Risk |
16 | Research |
16 | Prognosis |
16 | Pregnancy Complications, Infectious (virology) |
16 | Pregnancy Complications, Infectious (psychology) |
16 | Practice Guidelines as Topic |
16 | Health Services Accessibility (economics) |
16 | HIV-1 (pathogenicity) |
16 | HIV Infections (nursing) |
16 | Genetic Variation |
16 | Epidemics |
16 | Disclosure |
16 | Data Collection |
16 | Counseling (methods) |
16 | Clinical Trials as Topic |
16 | CD4-Positive T-Lymphocytes (immunology) |
16 | Body Mass Index |
15 | Viral Load (drug effects) |
15 | Mycobacterium tuberculosis (isolation & purification) |
15 | Mutation |
15 | Homosexuality, Male (psychology) |
15 | Developing Countries (statistics & numerical data) |
15 | Community Health Services |
15 | Antitubercular Agents (adverse effects) |
15 | Algorithms |
15 | Africa, Southern |
14 | United States (epidemiology) |
14 | Tuberculosis, Pulmonary (diagnosis) |
14 | South Africa (ethnology) |
14 | Sex Work |
14 | Seroepidemiologic Studies |
14 | Psychiatric Status Rating Scales |
14 | Professional-Patient Relations |
14 | Prenatal Care |
14 | Power (Psychology) |
14 | Peer Group |
14 | Marital Status |
14 | Kaplan-Meier Estimate |
14 | Health Personnel (psychology) |
14 | HIV Seronegativity |
14 | Evaluation Studies as Topic |
14 | Enzyme-Linked Immunosorbent Assay |
14 | Discrimination (Psychology) |
14 | Delivery of Health Care (organization & administration) |
14 | Cross-Cultural Comparison |
14 | Coinfection (epidemiology) |
14 | Africa, Eastern |
14 | Administration, Intravaginal |
13 | gag Gene Products, Human Immunodeficiency Virus (genetics) |
13 | Unsafe Sex |
13 | United Nations |
13 | Tuberculosis, Pulmonary (complications) |
13 | Transients and Migrants |
13 | Substance-Related Disorders (epidemiology) |
13 | Sputum (microbiology) |
13 | Senegal (epidemiology) |
13 | Sampling Studies |
13 | Religion |
13 | Policy Making |
13 | Needs Assessment |
13 | Mass Screening (utilization) |
13 | Marriage |
13 | Lost to Follow-Up |
13 | Infectious Disease Transmission, Vertical (statistics & numerical data) |
13 | Ethiopia |
13 | Depression (psychology) |
13 | Depression (epidemiology) |
13 | Condoms (statistics & numerical data) |
13 | Community Health Services (organization & administration) |
13 | Attitude to Health (ethnology) |
13 | Acquired Immunodeficiency Syndrome (diagnosis) |
13 | AIDS-Related Opportunistic Infections (pathology) |
13 | AIDS Vaccines (administration & dosage) |
13 | AIDS Serodiagnosis (methods) |
12 | Social Perception |
12 | RNA, Viral (genetics) |
12 | Program Development |
12 | Patient Compliance (psychology) |
12 | Neoplasms (epidemiology) |
12 | Mental Health |
12 | Medicine, African Traditional |
12 | Isoniazid (therapeutic use) |
12 | Intention |
12 | Income |
12 | History, 21st Century |
12 | Health Personnel |
12 | HIV Seropositivity (immunology) |
12 | HIV Infections (etiology) |
12 | HIV (isolation & purification) |
12 | Education |
12 | Communicable Disease Control (organization & administration) |
12 | Circumcision, Male |
12 | Circumcision, Male (statistics & numerical data) |
12 | Benzoxazines (therapeutic use) |
12 | African Continental Ancestry Group (statistics & numerical data) |
12 | Acquired Immunodeficiency Syndrome (history) |
12 | AIDS Serodiagnosis (statistics & numerical data) |
11 | Uterine Cervical Neoplasms (epidemiology) |
11 | Students (psychology) |
11 | Sex Education |
11 | Reverse Transcriptase Inhibitors (therapeutic use) |
11 | Public Health |
11 | Pregnant Women (psychology) |
11 | Pre-Exposure Prophylaxis |
11 | Poverty Areas |
11 | Poverty (psychology) |
11 | Population Surveillance (methods) |
11 | Population Characteristics |
11 | Morbidity |
11 | Mental Disorders (epidemiology) |
11 | Homosexuality, Male (statistics & numerical data) |
11 | Heterosexuality |
11 | Health Services Accessibility (standards) |
11 | Health Care Costs |
11 | HIV Seropositivity (complications) |
11 | Gender Identity |
11 | Forecasting |
11 | Food Supply |
11 | Family Health |
11 | Early Diagnosis |
11 | Confidence Intervals |
11 | Child, Orphaned (psychology) |
11 | Caregivers |
11 | Caregivers (statistics & numerical data) |
11 | CD8-Positive T-Lymphocytes (immunology) |
11 | Botswana (epidemiology) |
11 | Behavior |
11 | Anti-Infective Agents (therapeutic use) |
11 | Africa, Southern (epidemiology) |
10 | gag Gene Products, Human Immunodeficiency Virus (immunology) |
10 | Universities |
10 | Tuberculosis (microbiology) |
10 | Trimethoprim, Sulfamethoxazole Drug Combination (therapeutic use) |
10 | Swaziland (epidemiology) |
10 | Social Behavior |
10 | Sexually Transmitted Diseases (transmission) |
10 | Self Concept |
10 | Referral and Consultation |
10 | Prenatal Care (methods) |
10 | Pregnancy Complications, Infectious |
10 | Polymorphism, Single Nucleotide |
10 | Parents (psychology) |
10 | Organophosphonates (therapeutic use) |
10 | Organophosphonates (administration & dosage) |
10 | Organization and Administration |
10 | National Health Programs |
10 | Mothers (statistics & numerical data) |
10 | Mortality |
10 | Models, Statistical |
10 | Mental Disorders (psychology) |
10 | Leadership |
10 | Human Rights |
10 | HIV Seropositivity (transmission) |
10 | HIV Infections (metabolism) |
10 | Fertility |
10 | Drug Resistance, Viral (genetics) |
10 | Cooperative Behavior |
10 | Confidentiality |
10 | Biomarkers (blood) |
10 | Antitubercular Agents (administration & dosage) |
10 | Antiretroviral Therapy, Highly Active (economics) |
10 | Antifungal Agents (therapeutic use) |
10 | Adolescent Behavior (psychology) |
10 | Adenine (therapeutic use) |
10 | Adenine (administration & dosage) |
10 | Acquired Immunodeficiency Syndrome (virology) |
10 | AIDS-Related Opportunistic Infections (virology) |
10 | AIDS Vaccines (therapeutic use) |
9 | Zidovudine (therapeutic use) |
9 | Women (psychology) |
9 | Vulnerable Populations (statistics & numerical data) |
9 | Voluntary Programs (utilization) |
9 | Tuberculosis, Multidrug-Resistant (drug therapy) |
9 | Survival Rate |
9 | Substance-Related Disorders (complications) |
9 | Spouse Abuse (psychology) |
9 | Sex Workers |
9 | Sentinel Surveillance |
9 | Sarcoma, Kaposi (epidemiology) |
9 | Reverse Transcriptase Inhibitors (adverse effects) |
9 | Public Policy |
9 | Polymorphism, Genetic |
9 | Patient Acceptance of Health Care (ethnology) |
9 | Parent-Child Relations |
9 | Outcome Assessment (Health Care) |
9 | Nutritional Status |
9 | Neuropsychological Tests |
9 | Mortality (trends) |
9 | Models, Organizational |
9 | Models, Biological |
9 | Microbial Sensitivity Tests |
9 | Medication Adherence (ethnology) |
9 | Malnutrition (complications) |
9 | Lamivudine (therapeutic use) |
9 | Hospitals, Teaching |
9 | Healthcare Disparities |
9 | Health Services (utilization) |
9 | HIV Infections (microbiology) |
9 | HIV Antibodies (immunology) |
9 | HIV (genetics) |
9 | Geography |
9 | Flow Cytometry |
9 | Ethiopia (epidemiology) |
9 | Emigration and Immigration |
9 | Emigrants and Immigrants (statistics & numerical data) |
9 | Drug Interactions |
9 | Double-Blind Method |
9 | Diabetes Mellitus (epidemiology) |
9 | Depressive Disorder (epidemiology) |
9 | Depression (etiology) |
9 | Depression (diagnosis) |